Literature DB >> 21091062

In-center hemodialysis six times per week versus three times per week.

Glenn M Chertow, Nathan W Levin, Gerald J Beck, Thomas A Depner, Paul W Eggers, Jennifer J Gassman, Irina Gorodetskaya, Tom Greene, Sam James, Brett Larive, Robert M Lindsay, Ravindra L Mehta, Brent Miller, Daniel B Ornt, Sanjay Rajagopalan, Anjay Rastogi, Michael V Rocco, Brigitte Schiller, Olga Sergeyeva, Gerald Schulman, George O Ting, Mark L Unruh, Robert A Star, Alan S Kliger.   

Abstract

BACKGROUND: In this randomized clinical trial, we aimed to determine whether increasing the frequency of in-center hemodialysis would result in beneficial changes in left ventricular mass, self-reported physical health, and other intermediate outcomes among patients undergoing maintenance hemodialysis.
METHODS: Patients were randomly assigned to undergo hemodialysis six times per week (frequent hemodialysis, 125 patients) or three times per week (conventional hemodialysis, 120 patients) for 12 months. The two coprimary composite outcomes were death or change (from baseline to 12 months) in left ventricular mass, as assessed by cardiac magnetic resonance imaging, and death or change in the physical-health composite score of the RAND 36-item health survey. Secondary outcomes included cognitive performance; self-reported depression; laboratory markers of nutrition, mineral metabolism, and anemia; blood pressure; and rates of hospitalization and of interventions related to vascular access.
RESULTS: Patients in the frequent-hemodialysis group averaged 5.2 sessions per week; the weekly standard Kt/V(urea) (the product of the urea clearance and the duration of the dialysis session normalized to the volume of distribution of urea) was significantly higher in the frequent-hemodialysis group than in the conventional-hemodialysis group (3.54±0.56 vs. 2.49±0.27). Frequent hemodialysis was associated with significant benefits with respect to both coprimary composite outcomes (hazard ratio for death or increase in left ventricular mass, 0.61; 95% confidence interval [CI], 0.46 to 0.82; hazard ratio for death or a decrease in the physical-health composite score, 0.70; 95% CI, 0.53 to 0.92). Patients randomly assigned to frequent hemodialysis were more likely to undergo interventions related to vascular access than were patients assigned to conventional hemodialysis (hazard ratio, 1.71; 95% CI, 1.08 to 2.73). Frequent hemodialysis was associated with improved control of hypertension and hyperphosphatemia. There were no significant effects of frequent hemodialysis on cognitive performance, self-reported depression, serum albumin concentration, or use of erythropoiesis-stimulating agents.
CONCLUSIONS: Frequent hemodialysis, as compared with conventional hemodialysis, was associated with favorable results with respect to the composite outcomes of death or change in left ventricular mass and death or change in a physical-health composite score but prompted more frequent interventions related to vascular access. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov number, NCT00264758.).

Entities:  

Mesh:

Year:  2010        PMID: 21091062      PMCID: PMC3042140          DOI: 10.1056/NEJMoa1001593

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  37 in total

1.  Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial.

Authors:  D C Miskulin; N V Athienites; G Yan; A A Martin; D B Ornt; J W Kusek; K B Meyer; A S Levey
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

Review 2.  Daily hemodialysis: a systematic review.

Authors:  Rita S Suri; Gihad E Nesrallah; Rahul Mainra; Amit X Garg; Robert M Lindsay; Tom Greene; John T Daugirdas
Journal:  Clin J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 8.237

3.  A new automatic coil dialyzer system for 'daily' dialysis.

Authors:  John R DePalma; Edwin A Pecker; Morton H Maxwell
Journal:  Hemodial Int       Date:  2004-01-01       Impact factor: 1.812

4.  Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance.

Authors:  John T Daugirdas; Thomas A Depner; Tom Greene; Nathan W Levin; Glenn M Chertow; Michael V Rocco
Journal:  Kidney Int       Date:  2010-01-27       Impact factor: 10.612

5.  Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study.

Authors:  Juan Carlos Ayus; M Reza Mizani; Steven G Achinger; Ravi Thadhani; Alan S Go; Shuko Lee
Journal:  J Am Soc Nephrol       Date:  2005-07-20       Impact factor: 10.121

6.  Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.

Authors:  Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

7.  Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.

Authors:  E G Lowrie; N M Laird; T F Parker; J A Sargent
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

8.  Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.

Authors:  George O Ting; Carl Kjellstrand; Terri Freitas; Brian J Carrie; Shahrzad Zarghamee
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

9.  The quality of life of patients with end-stage renal disease.

Authors:  R W Evans; D L Manninen; L P Garrison; L G Hart; C R Blagg; R A Gutman; A R Hull; E G Lowrie
Journal:  N Engl J Med       Date:  1985-02-28       Impact factor: 91.245

10.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  297 in total

1.  Home haemodialysis in Ireland.

Authors:  D M Connaughton; A Jamal; J McWilliams; P O'Kelly; J Ormond; A Butler; N McEntee; E Tierney; G Lambe; M Denton; C Magee; P J Conlon
Journal:  Ir J Med Sci       Date:  2012-06-03       Impact factor: 1.568

2.  Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Authors:  Michel Jadoul; Jyothi Thumma; Douglas S Fuller; Francesca Tentori; Yun Li; Hal Morgenstern; David Mendelssohn; Tadashi Tomo; Jean Ethier; Friedrich Port; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

3.  Hemodialysis: Long weekend hemodialysis intervals--killing fields?

Authors:  Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2011-11-22       Impact factor: 28.314

4.  Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

Authors:  John T Daugirdas; Glenn M Chertow; Brett Larive; Andreas Pierratos; Tom Greene; Juan Carlos Ayus; Cynthia A Kendrick; Sam H James; Brent W Miller; Gerald Schulman; Isidro B Salusky; Alan S Kliger
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

5.  BP in Dialysis: Results of a Pilot Study.

Authors:  Dana C Miskulin; Jennifer Gassman; Ronald Schrader; Ambreen Gul; Manisha Jhamb; David W Ploth; Lavinia Negrea; Raymond Y Kwong; Andrew S Levey; Ajay K Singh; Antonia Harford; Susan Paine; Cynthia Kendrick; Mahboob Rahman; Philip Zager
Journal:  J Am Soc Nephrol       Date:  2017-12-06       Impact factor: 10.121

6.  Improving symptom management in hemodialysis patients: identifying barriers and future directions.

Authors:  Rachel Feldman; Nathaniel Berman; M Cary Reid; Jordan Roberts; Rouzi Shengelia; Kaylan Christianer; Brian Eiss; Ronald D Adelman
Journal:  J Palliat Med       Date:  2013-12       Impact factor: 2.947

Review 7.  How to overcome barriers and establish a successful home HD program.

Authors:  Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

Review 8.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 9.  Water quality in conventional and home haemodialysis.

Authors:  Matthew J Damasiewicz; Kevan R Polkinghorne; Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

Review 10.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.